Literature DB >> 7247366

In vitro activity of naftifine, a new antifungal agent.

A Georgopoulos, G Petranyi, H Mieth, J Drews.   

Abstract

Naftifine exhibits an interesting in vitro spectrum of activity against dermatophytes (38 strains; minimal inhibitory concentration [MIC] range 0.1 to 0.2 microgram/ml), aspergilli (6 strains; MIC range, 0.8 to 12.5 microgram/ml), Sporothrix schenckii (2 strains; MICs, 0.8 and 1.5 microgram/ml), and yeasts of the genus Candida (77 strains; MIC range, 1.5 to greater than 100 microgram/ml). Its degree of efficacy is unaffected by the organism density in the test medium, and it is primarily fungicidal against dermatophytes as well as yeasts. Its in vitro efficacy is pH dependent and rises with increasing pH values.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7247366      PMCID: PMC181441          DOI: 10.1128/AAC.19.3.386

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  2 in total

Review 1.  Antifungal agents.

Authors:  P F D'Arcy; E M Scott
Journal:  Prog Drug Res       Date:  1978

2.  [Deep-freeze preservation of fungi in liquid nitrogen as a basis for standardized inocula].

Authors:  A Georgopoulos
Journal:  Mykosen       Date:  1978-01
  2 in total
  14 in total

1.  Ultrastructural alterations induced by two ergosterol biosynthesis inhibitors, ketoconazole and terbinafine, on epimastigotes and amastigotes of Trypanosoma (Schizotrypanum) cruzi.

Authors:  K Lazardi; J A Urbina; W de Souza
Journal:  Antimicrob Agents Chemother       Date:  1990-11       Impact factor: 5.191

2.  Effects of butenafine hydrochloride, a new benzylamine derivative, on experimental dermatophytosis in guinea pigs.

Authors:  T Arika; M Yokoo; T Hase; T Maeda; K Amemiya; H Yamaguchi
Journal:  Antimicrob Agents Chemother       Date:  1990-11       Impact factor: 5.191

Review 3.  An overview of topical antifungal therapy in dermatomycoses. A North American perspective.

Authors:  A K Gupta; T R Einarson; R C Summerbell; N H Shear
Journal:  Drugs       Date:  1998-05       Impact factor: 9.546

Review 4.  Naftifine. A review of its antimicrobial activity and therapeutic use in superficial dermatomycoses.

Authors:  J P Monk; R N Brogden
Journal:  Drugs       Date:  1991-10       Impact factor: 9.546

5.  Antiproliferative synergism of the allylamine SF 86-327 and ketoconazole on epimastigotes and amastigotes of Trypanosoma (Schizotrypanum) cruzi.

Authors:  J A Urbina; K Lazardi; T Aguirre; M M Piras; R Piras
Journal:  Antimicrob Agents Chemother       Date:  1988-08       Impact factor: 5.191

6.  In vivo antimycotic activity of naftifine.

Authors:  G Petranyi; A Georgopoulos; H Mieth
Journal:  Antimicrob Agents Chemother       Date:  1981-03       Impact factor: 5.191

7.  Effect of the antimycotic drug naftifine on growth of and sterol biosynthesis in Candida albicans.

Authors:  N S Ryder; G Seidl; P F Troke
Journal:  Antimicrob Agents Chemother       Date:  1984-04       Impact factor: 5.191

8.  Antifungal activity of the allylamine derivative terbinafine in vitro.

Authors:  G Petranyi; J G Meingassner; H Mieth
Journal:  Antimicrob Agents Chemother       Date:  1987-09       Impact factor: 5.191

9.  Inhibition of squalene epoxidase by allylamine antimycotic compounds. A comparative study of the fungal and mammalian enzymes.

Authors:  N S Ryder; M C Dupont
Journal:  Biochem J       Date:  1985-09-15       Impact factor: 3.857

10.  In vitro antifungal activity of naftifine hydrochloride against dermatophytes.

Authors:  M Ghannoum; N Isham; A Verma; S Plaum; A Fleischer; B Hardas
Journal:  Antimicrob Agents Chemother       Date:  2013-07-01       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.